Nadine Van Roy

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma

  Scientific Reports · 2025-11-27

• Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma

  Journal of Molecular Diagnostics · 2025-10-18

• Targetable Genetic Alterations in High-Risk Neuroblastoma Patients Enrolled in the SIOPEN HR-NBL1 Study

  Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · 2025-05-25

• Abstract LB359: OBX-115 TIL from non-small cell lung cancer (NSCLC) are enriched for putative tumor-reactive, stem-like T cells with enhanced tumor cytotoxicity: Results from multimodal phenotyping analysis

  Cancer Research · 2025-04-25

• Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors

  Nature Medicine · 2025-03-25 · 39 citations

• Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitorsPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-03-02

• Abstract B001: Effective generation of potent tumor-infiltrating lymphocytes (TIL) expressing regulatable membrane-bound IL15 (mbIL15) and LIGHT (TNFSF14) from immune-excluded chondrosarcoma

  Cancer Immunology Research · 2025-02-23

• The potential use of targeted omics for the identification and monitoring of diabetic kidney disease

  Endocrine Abstracts · 2025-01-23

• NBAtlas: A harmonized single-cell transcriptomic reference atlas of human neuroblastoma tumors

  Cell Reports · 2024-10-01 · 23 citations

• Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid

  Clinical Epigenetics · 2024-07-05 · 20 citations